University of Nimes   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Nimes France (2007)

Organization Overview

First Clinical Trial
2007
NCT00370877
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Caremeau Hospital, Nimes | Caremeau Hospital, Nimes, France | CHU de Nimes | CHU de Nîmes | CHU de Nîmes (NUH) Place du Pr. Debré 30029 NIMES Cedex9 | CHU Nimes | CHU Nîmes | CHU Nîmes, France | EHPAD "Korian Mas de Lauze", 17, Chemin du puits de Louiset 30900 NIMES | Hôpital Sainte-Anne | NHS National Waiting Times Centre Board | Nimes University Hospital | Nîmes University hospital | Nîmes University Hospital | Nîmes University Hospital, France | University Hospital, Nîmes | University Hospital, Nimes, France | University Hospital of Nimes, France | University of Nimes

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 3)

Depression (Phase 3)

Depressive Disorder (Phase 3)

Depressive Disorder, Major (Phase 3)

Hemorrhage (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Postpartum Hemorrhage (Phase 4)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Respiratory Insufficiency (Phase 4)

Suicidal Ideation (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 18
  • # of Trial APIs: 27